![Philip T. Chase](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip T. Chase
Chief Executive Officer at Adimab LLC
Philip T. Chase active positions
Companies | Position | Start | End |
---|---|---|---|
Adimab LLC
![]() Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Chief Executive Officer | 2022-03-31 | - |
General Counsel | 2012-01-04 | 2022-05-08 |
Career history of Philip T. Chase
Former positions of Philip T. Chase
Companies | Position | Start | End |
---|---|---|---|
INVIVYD, INC. | Director/Board Member | - | - |
Transkaryotic Therapies, Inc.
![]() Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | General Counsel | - | - |
ALNYLAM PHARMACEUTICALS, INC. | General Counsel | - | - |
RenaMed Biologics, Inc.
![]() RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | General Counsel | - | - |
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | General Counsel | - | - |
Training of Philip T. Chase
The Trustees of Columbia University in The City of New York | Graduate Degree |
Colby College | Undergraduate Degree |
Statistics
International
United States | 9 |
Operational
General Counsel | 5 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
INVIVYD, INC. | Health Technology |
Private companies | 4 |
---|---|
EPIX Pharmaceuticals, Inc.
![]() EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
RenaMed Biologics, Inc.
![]() RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI. | Health Services |
Transkaryotic Therapies, Inc.
![]() Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Adimab LLC
![]() Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
- Stock Market
- Insiders
- Philip T. Chase
- Experience